Homology Medicines, Inc. Collaboration Agreements
6 Contracts & Agreements
- Collaboration and Option Agreement, dated August 12, 2022, by and between Q32 Bio Inc. and Horizon Therapeutics Ireland DAC (Filed With SEC on December 18, 2023)
- Second Amendment to Collaboration and License Agreement, dated October 30, 2020, between Homology Medicines, Inc. and Novartis Institutes for BioMedical Research, Inc (Filed With SEC on November 9, 2020)
- Amendment to Collaboration and License Agreement, dated December 17, 2018, between Homology Medicines, Inc. and Novartis Institutes for BioMedical Research, Inc (Filed With SEC on August 10, 2020)
- Collaboration and License Agreement, dated November 6, 2017, between the Registrant and Novartis Institutes for BioMedical Research, Inc (Filed With SEC on March 23, 2018)
- Collaboration and License Agreement, dated November 6, 2017, between the Registrant and Novartis Institutes for BioMedical Research, Inc (Filed With SEC on March 19, 2018)
- Collaboration and License Agreement, dated November 6, 2017, between the Registrant and Novartis Institutes for BioMedical Research, Inc (Filed With SEC on March 2, 2018)
